形状记忆聚合物填塞腹主动脉瘤囊后囊体积回归评估
结果显示SMP组1年囊回归>10%比例显著更高(79% vs 51%,P<.01),多变量分析中SMP治疗与囊回归独立相关(OR 4.13 [1.5-12.0],P<.01)。
要点
- EVAR联合SMP预防性囊填塞与标准EVAR相比1年囊回归率更高。
- SMP治疗是囊回归的独立相关因素(OR 4.13)。
- 填塞物距通畅分支血管更短与囊回归独立相关。
核心结论
- 预防性SMP囊填塞与标准EVAR相比,1年囊回归>10%的发生率显著更高。
- SMP治疗是囊回归的独立相关因素(OR 4.13 [1.5-12.0],P<.01)。
研究设计与样本
- 多中心回顾性两臂CTA囊回归分析,共97例严格筛选患者。
主要发现
- EVAR-PSM组1年囊回归>10%发生率为79%,对照组为51%(P<.01)。
- II型内漏发生率两组分别为40%和49%(P=.4)。
- 二次再干预率两组分别为2.4%和1.8%(P<.90),无动脉瘤破裂。
- 1年生存率两组分别为100%和96%(P=.50)。
- 多变量分析中,SMP治疗与囊回归独立相关(OR 4.13 [1.5-12.0],P<.01)。
关键数值与推荐
- 囊回归定义为30天至1年CTA之间囊体积减少>10%。
- EVAR-PSM组平均每例植入59个填塞物,平均填塞密度为129%。
- 治疗组内,填塞物距通畅分支血管距离更短与囊回归独立相关(OR 0.54 [0.30-0.71],P<.01)。
- 填塞密度和血栓负荷与囊回归无独立关联。
临床怎么用
- 对于符合筛选标准的肾下腹主动脉瘤EVAR患者,可考虑预防性SMP囊填塞以促进囊回归。
- 填塞物应尽量靠近通畅的分支血管放置,以增强囊重塑效果。
- 仍需监测II型内漏和再干预,尽管本研究两组间无显著差异。
局限性
- 回顾性研究设计,两组治疗时间窗不同(2019-2023 vs 2014-2019)。
- 样本量较小(共97例),且患者经过高度筛选。
- 对照组来自单中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aneurysm repair (EVAR) is widely used for infrarenal abdominal aortic aneurysms, offering improved short-term outcomes compared with open repair. However, long-term durability is limited by the need for surveillance and reintervention, often related to sac growth and endoleak. Prophylactic sac embolization using shape memory polymer (SMP) plugs-a porous, bioabsorbable polyurethane scaffold designed to promote thrombosis and tissue ingrowth-has been evaluated in early feasibility studies. This study represents the first global, multicenter real-world analysis of SMP use during EVAR. METHODS: A multicenter, retrospective, two-arm computed tomography angiography (CTA)-based sac regression analysis was performed in 97 highly selected patients meeting prespecified eligibility criteria. Fifty-six patients underwent EVAR with prophylactic sac management (EVAR-PSM) using SMP between 2019 and 2023, including 31 treated prospectively in the abdominal aortic aneurysm-SHAPE early feasibility studies and 25 treated in real-world practice. Forty-one patients underwent standard EVAR between 2014 and 2019 at a single center and met identical inclusion/exclusion criteria, including aneurysm size thresholds, sac volume parameters, infrarenal stent grafts use within instructions for use, serial CTA availability, and exclusion of adjunctive branch vessel embolization. Sac regression (>10% volume reduction between 30-day and 1-year CTA) was assessed. Thrombus burden and patent accessory vessels were analyzed in all patients; packing density and plug proximity to accessory vessels were analyzed in the EVAR-PSM group. RESULTS: Hypertension was more prevalent in controls (98% vs 77%, P = .01), whereas prior myocardial infarction was less common (0% vs 17%, P = .01). In the treatment group, a mean of 59 plugs per patient were implanted, yielding a mean packing density of 129%. Sac regression >10% at 1 year occurred more frequently in the EVAR-PSM group (79% vs 51%, P < .01). Type II endoleak occurred in 40% vs 49% (P = .4), and secondary reintervention rates were similar (2.4% vs 1.8%, P < .90). No aneurysm ruptures occurred. One-year survival was similar between groups (100% vs 96%, P = .50). On multivariable analysis, SMP treatment was independently associated with sac regression (odds ratio: 4.13 [1.5-12.0], P < .01). Within the treatment group, shorter plug distance to patent branch vessels was independently associated with sac regression (odds ratio: 0.54 [0.30-0.71], P < .01), while packing density and thrombus burden were not. CONCLUSIONS: In this multicenter analysis of controlled and real-world data, prophylactic sac embolization with SMP was associated with significantly greater sac regression compared with standard EVAR. Effective sac remodeling appears influenced by plug proximity to branch vessels.
引用
- Rao A, Holden A, Reijnen MMPJ, et al. Evaluation of sac volume regression after aortic aneurysm sac embolization with shape memory polymer plugs in patients undergoing endovascular aneurysm repair. J Vasc Surg. 2026. PMID: 42031147. doi:10.1016/j.jvs.2026.03.792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。